{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:54Z","timestamp":1784764854692,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003286"],"award-info":[{"award-number":["82003286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073099"],"award-info":[{"award-number":["82073099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ5462"],"award-info":[{"award-number":["2024JJ5462"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40054"],"award-info":[{"award-number":["2021JJ40054"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019092","name":"Science Fund for Distinguished Young Scholars of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ10096"],"award-info":[{"award-number":["2023JJ10096"]}],"id":[{"id":"10.13039\/501100019092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117315","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T10:00:15Z","timestamp":1723802415000},"page":"117315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["c-Myc-XRCC2-FOS axis promotes the proliferation and the resistance to Doxorubicin of NSCLC"],"prefix":"10.1016","volume":"179","author":[{"given":"Peihe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann. Glob. Health"},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib2","first-page":"45","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Conte Oncol. (Pozn. )"},{"issue":"12","key":"10.1016\/j.biopha.2024.117315_bib3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"issue":"49","key":"10.1016\/j.biopha.2024.117315_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208904119","article-title":"The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2024.117315_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fon-2019-0458","article-title":"Molecular avenues in targeted Doxorubicin cancer therapy","volume":"16","author":"Roychoudhury","year":"2020","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117315_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41416-022-01929-w","article-title":"Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate","volume":"127","author":"Rizzo","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2024.117315_bib7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","article-title":"Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study","volume":"17","author":"Rizzo","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2024.117315_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.117315_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10787-023-01148-6","article-title":"A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis","volume":"31","author":"Guo","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2024.117315_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173105","article-title":"miR-199a-5p is involved in Doxorubicin resistance of non-small cell lung cancer (NSCLC) cells","volume":"878","author":"Jin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"37","key":"10.1016\/j.biopha.2024.117315_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/EDBK_175188","article-title":"Role of chemotherapy and targeted theraearly-stagenon-small cell lung cancer","author":"Gadgeel","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.biopha.2024.117315_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117315_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1039121","article-title":"The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"9","author":"Guven","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.biopha.2024.117315_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/imt-2020-0179","article-title":"Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis","volume":"13","author":"Dall'Olio","year":"2021","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biopha.2024.117315_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2024.117315_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.117315_bib17","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00358","article-title":"PROREPAIR-B: A Prospective cohort study of the impact of germline DNA repair mutations on the outcomes of patients with metastatic castration-resistant prostate cancer","author":"Castro","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117315_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjc.6604453","article-title":"Rapid progression of prostate cancer in men with a BRCA2 mutation","volume":"99","author":"Narod","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117315_bib19","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-09-2871","article-title":"Germline BRCA mutations denote a clinicopathologic subset of prostate cancer","volume":"16","author":"Gallagher","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"7970","key":"10.1016\/j.biopha.2024.117315_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-023-06179-1","article-title":"Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor","volume":"619","author":"Greenhough","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2024.117315_bib21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jmedgenet-2017-105145","article-title":"XRCC2 mutation causes meiotic arrest, azoospermia and infertility","volume":"55","author":"Yang","year":"2018","journal-title":"J. Med Genet"},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib22","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1080\/21655979.2021.1964193","article-title":"Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer","volume":"12","author":"Fan","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2024.117315_bib23","doi-asserted-by":"crossref","DOI":"10.23736\/S0031-0808.21.04472-4","article-title":"Correlation analysis between XRCC2 polymorphism and radiosensitivity of non-small cell lung cancer[J]","author":"He","year":"2021","journal-title":"Panminerva Med"},{"key":"10.1016\/j.biopha.2024.117315_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.04.026","article-title":"XRCC2 repairs mitochondrial DNA damage and fuels malignant behavior in hepatocellular carcinoma","volume":"512","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s10020-021-00316-0","article-title":"Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients","volume":"27","author":"Liu","year":"2021","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.117315_bib26","first-page":"1743","article-title":"Association of XRCC2 rs3218536 polymorphism with susceptibility of breast and ovarian cancer: a systematic review and meta-analysis[J]","volume":"18","author":"Kamali","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"52","key":"10.1016\/j.biopha.2024.117315_bib27","doi-asserted-by":"crossref","first-page":"86621","DOI":"10.18632\/oncotarget.13361","article-title":"Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib28","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14737140.2018.1409624","article-title":"Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer","volume":"18","author":"Nagasaka","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7314\/APJCP.2013.14.1.449","article-title":"Polymorphisms in DNA repair genes and risk of glioma and meningioma","volume":"14","author":"Luo","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.biopha.2024.117315_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jmedgenet-2017-104588","article-title":"Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks","volume":"54","author":"Decker","year":"2017","journal-title":"J. Med. Genet"},{"issue":"20","key":"10.1016\/j.biopha.2024.117315_bib32","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.7150\/jca.59273","article-title":"Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"issue":"31","key":"10.1016\/j.biopha.2024.117315_bib33","doi-asserted-by":"crossref","first-page":"32193","DOI":"10.18632\/oncotarget.4975","article-title":"XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy","volume":"6","author":"Qin","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2024.117315_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21873\/cgp.20176","article-title":"FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma","volume":"17","author":"Panagopoulos","year":"2020","journal-title":"Cancer Genom. Proteom."},{"issue":"43","key":"10.1016\/j.biopha.2024.117315_bib35","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1038\/sj.onc.1206781","article-title":"The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis","volume":"22","author":"Mikula","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2024.117315_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/MCB.16.1.211","article-title":"Induction of apoptosis by c-Fos protein","volume":"16","author":"Preston","year":"1996","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117315_bib37","first-page":"2757","article-title":"Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome","volume":"16","author":"Fisler","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2024.117315_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02940306","article-title":"Prognostic significance of loss of c-fos protein in gastric carcinoma","volume":"13","author":"Jin","year":"2007","journal-title":"Pathol. Oncol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.117315_bib39","first-page":"3783","article-title":"XRCC2 reduced the sensitivity of NSCLC to radio-chemotherapy by arresting the cell cycle","volume":"14","author":"Shan","year":"2022","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.117315_bib40","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mc.22248","article-title":"Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair","volume":"54","author":"Oji","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.biopha.2024.117315_bib41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers16101835","article-title":"Prognostic significance of the royal marsden hospital (RMH) score in patients with cancer: a systematic review and meta-analysis","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.biopha.2024.117315_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5842","article-title":"Development and validation of a deep learning model for non-small cell lung cancer survival","volume":"3","author":"She","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"14","key":"10.1016\/j.biopha.2024.117315_bib43","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.18632\/aging.204886","article-title":"Characterization of platelet-related genes and constructing signature combined with immune-related genes for predicting outcomes and immunotherapy response in lung squamous cell carcinoma","volume":"15","author":"Zhao","year":"2023","journal-title":"Aging (Albany NY)"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:03:42Z","timestamp":1784761422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224011995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S0753332224011995"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117315","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-Myc-XRCC2-FOS axis promotes the proliferation and the resistance to Doxorubicin of NSCLC","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117315"}}